Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Endogenous opiates may affect various aspects of reproductive and metabolic function in patients with polycystic ovary syndrome (PCOS). This study evaluated long-term inhibition of the opioid system using naltrexone in clomiphene citrate (CC)-resistant women with PCOS. METHODS: A group of 30 infertile females with PCOS were evaluated; all subjects were obese, hyperandrogenic and hyperinsulinemic; 16 patients were amenorrhic and 14 were oligomenorrhic. All subjects received natrexone (50 mg p.o. daily) for 6 months. Patients who did not ovulate after 12 weeks of naltrexone monotherapy, also received CC (starting at 50 mg/day for 5 days and, for non-responders, increasing it up to 150 mg/day). RESULTS: Of the 30 women, 3 ovulated during naltrexone monotherapy and 19 of the remaining 27 ovulated during naltrexone + CC therapy. There were no conceptions during naltrexone monotherapy, but 9 of 27 women (33.3%) conceived during naltrexone + CC; there was one missed abortion at 9 weeks, one preterm delivery at 34 weeks and seven term live births. Naltrexone therapy was also followed by significant reductions in BMI, fasting serum insulin, luteinizing hormone (LH), LH/follicle-stimulating hormone ratio and testosterone. CONCLUSIONS: In this preliminary trial, naltrexone improved endocrine and metabolic function in women with CC-resistant PCOS. Furthermore, naltrexone restored CC sensitivity in the majority of subjects, resulting in a significant number of pregnancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although some studies have been inconclusive,75,76 the opioid antagonist naltrexone is effective in reducing endocrine symptoms in women with PCOS,77–79 also suggesting that high β-endorphin levels are a feature of this condition.”
From Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone (2023) · cites this paper as [78]
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712 · cited 1×
“Prevalence of PCOS has been studied in several populations and it appears that it affects as many as 5–10% of women of reproductive age (Diamanti-Kandarakis et al., 1999; Azziz et al., 2004).”
BackgroundCLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506 · cited 2×
“METHODS: A group of 30 infertile females with PCOS were evaluated; all subjects were obese, hyperandrogenic and hyperinsulinemic; 16 patients were amenorrhic and 14 were oligomenorrhic.”
BackgroundMethodDiamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110 · cited 1×
“Prevalence of PCOS has been studied in several populations and it appears that it affects as many as 5–10% of women of reproductive age (Diamanti-Kandarakis et al., 1999; Azziz et al., 2004).”
BackgroundPrevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981 · cited 1×
“Polycystic ovarian morphology was diagnosed as the presence of more than 12 follicles (2004) with diameter 8 mm arranged peripherally or scattered throughout an echodense core of stroma (Adams et al., 1986; Polson et al., 1988).”
BackgroundPOLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
Polson, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 906
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743 · cited 2×
“These effects may be related to a decreased LH and improvement of hyperinsulinemia, resulting in lower ovarian androgen production (Nestler and Jakubowicz, 1996).”
BackgroundLegro, R. S., Finegood, D., & Dunaif, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5054 · Cited by 673 · cited 2×
“5 mg/unit are consistent with insulin resistance (Legro et al., 1998).”
BackgroundInfluentialProgress in Clinical and Biological Research
Rumsby, M. G. (1984) · Neurochemistry International · doi:10.1016/0197-0186(84)90053-6 · Cited by 534
Talbott, E. O., Guzick, D. S., Sutton-Tyrrell, K., McHugh-Pemu, K. P., Zborowski, J. V., Remsberg, K. E., & Kuller, L. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2414 · Cited by 511 · cited 1×
“It is a complex disorder involving the CNS-hypothalamus, the pituitary gland, the adrenal glands and the ovaries (Talbott et al., 2000; Doi et al., 2005).”
BackgroundMorales, A. J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2854 · Cited by 455 · cited 1×
“Salient features of PCOS include hyperandrogenism and chronic anovulation, often in association with insulin resistance, as well as alterations in GnRH pulse frequency and gonadotrophin release (Barnes and Rosenfield, 1989; Morales et al., 1996; Blank et al., 2007).”
BackgroundLegro, R. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2694 · Cited by 367
The Importance of Diagnosing the Polycystic Ovary Syndrome
Lobo, R. A., & Carmina, E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00010 · Cited by 309 · cited 1×
“Although multiple alterations in the function of these organs have been documented, it is uncertain which, if any, of these organs initiates the development of PCOS (Chang et al., 2000; Lobo and Carmina, 2000).”
BackgroundKolodziejczyk, B., Duleba, A. J., Spaczynski, R. Z., & Pawelczyk, L. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00501-x · Cited by 255 · cited 2×
“with a Ferriman–Gallwey score 7 (Ferriman and Gallwey, 1961) and/or acne (Kolodziejczyk et al., 2000).”
BackgroundIs polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?
Sverrisdóttir, Y. B., Mogren, T., Kataoka, J., Janson, P. O., & Stener-Victorin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00725.2007 · Cited by 216 · cited 1×
“In a study directly evaluating sympathetic nerve activity, Sverrisdottir et al. (2008) found that women with PCOS have significantly higher muscle vascular bed sympathetic nerve activity than matched controls.”
BackgroundPassive Smoking Affects Endothelium and Platelets
Davis, J. W. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.2.386 · Cited by 174
Acién, P., Quereda, F., Matallı́n, P., Villarroya, E., López-Fernández, J. A., Acién, M., Mauri, M., & Alfayate, R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00184-3 · Cited by 170 · cited 1×
“The OGTT was performed after an overnight fast, with a 100 g glucose load administered orally and blood sampled for blood glucose and insulin at 0 and 120 min (Acien et al., 1999).”
MethodThe Polycystic Ovary Syndrome: Pathogenesis and Treatment
Barnes, R., & Rosenfield, R. L. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-5-386 · Cited by 163 · cited 2×
“Salient features of PCOS include hyperandrogenism and chronic anovulation, often in association with insulin resistance, as well as alterations in GnRH pulse frequency and gonadotrophin release (Barnes and Rosenfield, 1989; Morales et al., 1996; Blank et al., 2007).”
BackgroundNormal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome
Ovesen, P. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1636 · Cited by 138 · cited 2×
“80 (Ovesen et al., 1993) and a fasting glucose to fasting insulin ratio ,4.”
BackgroundInfluentialLegro, R. S., Chiu, P., Kunselman, A. R., Bentley, C. M., Dodson, W. C., & Dunaif, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0219 · Cited by 125 · cited 2×
“All subjects had primary infertility for over 1 year, chronic anovulation with a progesterone level ,4 ng/ml, and a body mass index (BMI) .25 kg/m2 (Legro et al., 2005), android obesity with waist/ hip ratio (WHR) .0.80 (Ovesen et al., 1993) and a fasting glucose to fasting insulin ratio ,4.5…”
BackgroundInfluentialNeuroendocrine Effects of Androgens in Adult Polycystic Ovary Syndrome and Female Puberty
Blank, S., McCartney, C., Helm, K., & Marshall, J. (2007) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-984741 · Cited by 116 · cited 1×
“Salient features of PCOS include hyperandrogenism and chronic anovulation, often in association with insulin resistance, as well as alterations in GnRH pulse frequency and gonadotrophin release (Barnes and Rosenfield, 1989; Morales et al., 1996; Blank et al., 2007).”
BackgroundCurrent Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in Youth
Harwood, K., Vuguin, P., & DiMartino-Nardi, J. (2007) · Hormone Research in Paediatrics · doi:10.1159/000101538 · Cited by 110 · cited 1×
“It is known that weight loss is the most physiologic method of inducing ovulation and improvement of insulin sensitivity (Harwood et al., 2007; Nelson and Fleming, 2007).”
BackgroundHeart Rate Variability in Young Women with Polycystic Ovary Syndrome
Yildirir, A., Aybar, F., Kabakci, G., Yarali, H., & Oto, A. (2006) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2006.00122.x · Cited by 105 · cited 1×
“Several other studies have indirectly measured the nerve activity in women with PCOS by comparing the heart autonomic innervation characteristics of women with PCOS and control subjects (Yildirir et al., 2006; Tekin et al., 2007; Giallauria et al., 2008).”
BackgroundChang, P. L., Lindheim, S. R., Lowre, C., Ferin, M., Gonzalez, F., Berglund, L., Carmina, E., Sauer, M. V., & Lobo, R. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6452 · Cited by 99 · cited 1×
“Although multiple alterations in the function of these organs have been documented, it is uncertain which, if any, of these organs initiates the development of PCOS (Chang et al., 2000; Lobo and Carmina, 2000).”
BackgroundMitwally, M. F. M., Kuscu, N. K., & Yalcinkaya, T. M. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2700 · Cited by 89
Tekin, G., Tekin, A., Kılıçarslan, E. B., Haydardedeoğlu, B., Katırcıbaşı, T., Koçum, T., Erol, T., Çölkesen, Y., Sezgin, A. T., & Müderrisoğlu, H. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.037 · Cited by 86 · cited 1×
“Several other studies have indirectly measured the nerve activity in women with PCOS by comparing the heart autonomic innervation characteristics of women with PCOS and control subjects (Yildirir et al., 2006; Tekin et al., 2007; Giallauria et al., 2008).”
BackgroundObesity and reproduction: impact and interventions
Nelson, S. M., & Fleming, R. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32825e1d70 · Cited by 78 · cited 1×
“It is known that weight loss is the most physiologic method of inducing ovulation and improvement of insulin sensitivity (Harwood et al., 2007; Nelson and Fleming, 2007).”
BackgroundRelationship Between Persistence of Abdominal Symptoms and Successful Outcome After Cholecystectomy
Weinert, C. R., Arnett, D., Jacobs, D., & Kane, R. L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.989 · Cited by 76
PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic–pituitary–adrenal axis?
Doi, S. A. R., Towers, P. A., Scott, C., & Al-Shoumer, K. A. S. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.06.024 · Cited by 67 · cited 1×
“It is a complex disorder involving the CNS-hypothalamus, the pituitary gland, the adrenal glands and the ovaries (Talbott et al., 2000; Doi et al., 2005).”
BackgroundBrotman, A. W., Herzog, D. B., & Woods, S. W. (1984) · PubMed · Cited by 66
Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., & Genazzani, A. R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02955-2 · Cited by 62 · cited 10×
“In a previous study of 10 subjects, Fruzzetti et al. (2002) observed a statistically non-significant trend toward lower LH following naltrexone treatment; this was likely due to the limited power of the study.”
BackgroundResultInfluentialStimulatory and Inhibitory Effects of the Opioids on Gonadotropin Secretion
Piva, F., Limonta, P., Maggi, R., & Martini, L. (2008) · Neuroendocrinology · doi:10.1159/000124495 · Cited by 62 · cited 1×
“Growing evidence points to a prominent and complex relationship between endogenous opiates, insulin and GnRH output (Piva et al., 1986).”
BackgroundCozzolino, D. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.713 · Cited by 58 · cited 1×
“Exaggerated b-pancreatic cell responsiveness to b-endorphin stimulation in human obesity is well documented (Cozzolino et al., 1996).”
BackgroundObstetric and neonatal outcomes associated with maternal naltrexone exposure
Hulse, G. K., O'Neill, G., Pereira, C. G. D. S., & Brewer, C. (2001) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2001.tb01322.x · Cited by 56 · cited 1×
“Naltrexone should be used in pregnancy only when the potential benefit justifies the potential risk to the fetus (Hulse et al., 2001).”
BackgroundGiallauria, F., Palomba, S., Manguso, F., Vitelli, A., Maresca, L., Tafuri, D., Lombardi, G., Colao, A., Vigorito, C., & Orio, F. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03004.x · Cited by 51 · cited 1×
“Several other studies have indirectly measured the nerve activity in women with PCOS by comparing the heart autonomic innervation characteristics of women with PCOS and control subjects (Yildirir et al., 2006; Tekin et al., 2007; Giallauria et al., 2008).”
BackgroundOpioid modulation of taste responses in the nucleus of the solitary tract
Li, C., Davis, B. J., & Smith, D. V. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03973-2 · Cited by 47 · cited 1×
“By blocking the effects of opiates, narcotic antagonists also prevent the development of physical dependence and tolerance to opiate drugs (Li et al., 2003).”
BackgroundLanzone, A., Fulghesu, A. M., Cucinelli, F., Ciampelli, M., Caruso, A., & Mancuso, S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530590 · Cited by 32 · cited 2×
“…2564 Advance Access publication on July 18, 2008 by guest on A pril 25, 2016 http://hum rep.oxfordjournals.org/ D ow nloaded from control (Hadziomerovic et al., 2006), and thus may play a role in the pathogenesis of conditions such as obesity and PCOS (Lanzone et al., 1995).”
BackgroundRole of Opioid Antagonists in the Treatment of Women with Glucoregulation Abnormalities
Guido, M., Romualdi, D., & Lanzone, A. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776055895 · Cited by 28 · cited 2×
“A link between opioids and PCOS-related hyperinsulinism is suggested by the finding of altered central opioid tone evidenced by elevated b-endorphins levels, which directly correlated with body weight (Guido et al., 2006).”
BackgroundNormalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women
Hadžiomerović, D., Rabenbauer, B., & Wildt, L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.039 · Cited by 26 · cited 3×
“control (Hadziomerovic et al., 2006), and thus may play a role in the pathogenesis of conditions such as obesity and PCOS (Lanzone et al.”
BackgroundResultLanzone, A., Apa, R., Fulghesu, A. M., Cutillo, G., Caruso, A., & Mancuso, S. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55851-8 · Cited by 26 · cited 3×
“Lanzone et al. (1993) have shown that both acute and chronic inhibition of the opioid system significantly decreases the insulin response to an oral glucose tolerance test (OGTT) in a group of hyperinsulinemic PCOS patients without significant change in plasma androgen levels.”
BackgroundResultChang, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.995 · Cited by 25
Fulghesu, A. M., Ciampelli, M., Belosi, C., Apa, R., Guido, M., Caruso, A., Mancuso, S., & Lanzoneal, A. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343880 · Cited by 21 · cited 2×
“These findings agree with most, but not all, previous reports (Villa et al., 1999; Fulghesu et al., 2001; Fruzzetti et al., 2002; Hadziomerovic et al., 2006).”
BackgroundResultNORMAL AND ABNORMAL PUBERTAL DEVELOPMENT
Winter, J. S. D., Faiman, C., & Reyes, F. I. (1978) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-197803000-00006 · Cited by 20 · cited 1×
“LH, FSH and SHBG were measured by chemiluminescent enzyme immunoassay (Immulite 2000; Diagnostic Products Corporation, Los Angeles, CA, USA) according to the method described by Winter et al. (1978).”
MethodCouzinet, B., Young, J., Brailly, S., Chanson, P., & SCHAISON, G. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608262 · Cited by 19 · cited 1×
“On the other hand, some researchers did not observe significant changes in BMI after naltrexone therapy (Couzinet et al., 1995).”
BackgroundVilla, P., Valle, D., Mancini, A., Marinis, L. D., Pavone, V., Fulghesu, A. M., Mancuso, S., & Lanzone, A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00405-1 · Cited by 18 · cited 2×
“These observations are in agreement with several previous studies (Givens and Kurtz, 1986; Apa et al., 1995; Villa et al., 1999; Fruzzetti et al., 2002).”
ResultGuido, M., Pavone, V., Ciampelli, M., Murgia, F., Fulghesu, A. M., Apa, R., Caruso, A., Mancuso, S., & Lanzone, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4775 · Cited by 17 · cited 1×
“This effect is also likely specific to individual patient populations, since comparable findings were observed by some (Fruzzetti et al., 2002), but not other investigators (Lanzone et al., 1993; Guido et al., 1998).”
ResultLanzone, A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3501 · Cited by 12
Couzinet, B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2102 · Cited by 10
Homburg, R. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.1995 · Cited by 10
Understanding the polycystic ovary syndrome.
Givens, J. R., & Kurtz, B. R. (1986) · PubMed · Cited by 6
Central glucagon antagonizes morphine- and stress-induced antinociception in the mouse.
Ds, M., Amir, S., & Holaday, J. W. (1986) · PubMed · Cited by 2
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phase
Apa, R., Fulghesu, A. M., Lanzone, A., Guido, M., Villa, P., Pavone, V., Caruso, A., & Mancuso, S. (1995) · Gynecological Endocrinology · doi:10.3109/09513599509160458 · Cited by 1 · cited 1×
“These observations are in agreement with several previous studies (Givens and Kurtz, 1986; Apa et al., 1995; Villa et al., 1999; Fruzzetti et al., 2002).”
Result
Research works printed but not linked: 3
- Guido, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 1742, 10.1210/jc.83.5.1742 · doi:10.1210/jc.83.5.1742
- Malcolm, 1986, NIDA research monograph, 75, 371
- 1988, 1, 870
Cited by
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Jedel, E., Labrie, F., Odén, A., Holm, G., Nilsson, L., Janson, P. O., Lind, A.-K., Ohlsson, C., & Stener-Victorin, E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2010 · Cited by 223
Polycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation Induction
Johansson, J., & Stener‐Victorin, E. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/762615 · Cited by 150
Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial
Johansson, J., Redman, L., Veldhuis, P. P., Sazonova, A., Labrie, F., Holm, G., Johannsson, G., & Stener-Victorin, E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2013 · Cited by 131
Androgens and polycystic ovary syndrome
Nisenblat, V., & Norman, R. J. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832afd4d · Cited by 125
Metadata
- Authors
- Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A.
- Affiliations
- Benha University (EG)
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-29
- Volume
- 23
- Issue
- 11
- Pages
- 2564-2569
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2156291382
- Cited by
- 58
- References
- 53
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 3 · 2016: 3 · 2014: 3 · 2013: 7 · 2012: 2
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- naltrexone, polycystic ovary syndrome, clomiphene citrate resistance, opioid system, ovulation induction, infertility, hyperandrogenism, hyperinsulinemia, luteinizing hormone, testosterone, body mass index, pregnancy outcomes
- MeSH terms
- Adolescent, Adult, Analgesics, Opioid, Clomiphene, Drug Resistance, Estrogen Antagonists, Female, Humans, Infertility, Female, Luteinizing Hormone, Naltrexone, Narcotic Antagonists, Polycystic Ovary Syndrome, Pregnancy, Body Mass Index, Pregnancy Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.